Report ID: IBI1622126 | Category: Pharma & Healthcare | Pages: 130 | Format: PDF | Published Date: August 18,2023
1 Market Overview 1.1 Cycloplegic Agents Introduction 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Cycloplegic Agents Consumption Value by Type: 2019 Versus 2023 Versus 2030 1.3.2 Atropine 1.3.3 Cyclopentolate 1.3.4 Houmatopin 1.3.5 Tropicamide 1.3.6 Scopolamine 1.4 Market Analysis by Application 1.4.1 Overview: Global Cycloplegic Agents Consumption Value by Application: 2019 Versus 2023 Versus 2030 1.4.2 Pseudomyopia 1.4.3 Optometry 1.4.4 Uveitis 1.4.5 Other 1.5 Global Cycloplegic Agents Market Size & Forecast 1.5.1 Global Cycloplegic Agents Consumption Value (2019 & 2022 & 2030) 1.5.2 Global Cycloplegic Agents Sales Quantity (2019-2030) 1.5.3 Global Cycloplegic Agents Average Price (2019-2030) 2 Manufacturers Profiles 2.1 Pfizer Inc 2.1.1 Pfizer Inc Details 2.1.2 Pfizer Inc Major Business 2.1.3 Pfizer Inc Cycloplegic Agents Product and Services 2.1.4 Pfizer Inc Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.1.5 Pfizer Inc Recent Developments/Updates 2.2 Henry Schein, Inc 2.2.1 Henry Schein, Inc Details 2.2.2 Henry Schein, Inc Major Business 2.2.3 Henry Schein, Inc Cycloplegic Agents Product and Services 2.2.4 Henry Schein, Inc Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.2.5 Henry Schein, Inc Recent Developments/Updates 2.3 Actiza Pharmaceutical Private Limited 2.3.1 Actiza Pharmaceutical Private Limited Details 2.3.2 Actiza Pharmaceutical Private Limited Major Business 2.3.3 Actiza Pharmaceutical Private Limited Cycloplegic Agents Product and Services 2.3.4 Actiza Pharmaceutical Private Limited Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.3.5 Actiza Pharmaceutical Private Limited Recent Developments/Updates 2.4 Hameln Pharma Gmbh 2.4.1 Hameln Pharma Gmbh Details 2.4.2 Hameln Pharma Gmbh Major Business 2.4.3 Hameln Pharma Gmbh Cycloplegic Agents Product and Services 2.4.4 Hameln Pharma Gmbh Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.4.5 Hameln Pharma Gmbh Recent Developments/Updates 2.5 Sigma Pharmaceuticals, LLC 2.5.1 Sigma Pharmaceuticals, LLC Details 2.5.2 Sigma Pharmaceuticals, LLC Major Business 2.5.3 Sigma Pharmaceuticals, LLC Cycloplegic Agents Product and Services 2.5.4 Sigma Pharmaceuticals, LLC Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.5.5 Sigma Pharmaceuticals, LLC Recent Developments/Updates 2.6 Biomedica 2.6.1 Biomedica Details 2.6.2 Biomedica Major Business 2.6.3 Biomedica Cycloplegic Agents Product and Services 2.6.4 Biomedica Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.6.5 Biomedica Recent Developments/Updates 2.7 Prudence Pharma Chem 2.7.1 Prudence Pharma Chem Details 2.7.2 Prudence Pharma Chem Major Business 2.7.3 Prudence Pharma Chem Cycloplegic Agents Product and Services 2.7.4 Prudence Pharma Chem Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.7.5 Prudence Pharma Chem Recent Developments/Updates 2.8 Heer Pharma Pvt. Ltd 2.8.1 Heer Pharma Pvt. Ltd Details 2.8.2 Heer Pharma Pvt. Ltd Major Business 2.8.3 Heer Pharma Pvt. Ltd Cycloplegic Agents Product and Services 2.8.4 Heer Pharma Pvt. Ltd Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.8.5 Heer Pharma Pvt. Ltd Recent Developments/Updates 2.9 Fresenius Kabi AG 2.9.1 Fresenius Kabi AG Details 2.9.2 Fresenius Kabi AG Major Business 2.9.3 Fresenius Kabi AG Cycloplegic Agents Product and Services 2.9.4 Fresenius Kabi AG Cycloplegic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2022) 2.9.5 Fresenius Kabi AG Recent Developments/Updates 3 Competitive Environment: Cycloplegic Agents by Manufacturer 3.1 Global Cycloplegic Agents Sales Quantity by Manufacturer (2019-2022) 3.2 Global Cycloplegic Agents Revenue by Manufacturer (2019-2022) 3.3 Global Cycloplegic Agents Average Price by Manufacturer (2019-2022) 3.4 Market Share Analysis (2021) 3.4.1 Producer Shipments of Cycloplegic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2021 3.4.2 Top 3 Cycloplegic Agents Manufacturer Market Share in 2021 3.4.2 Top 6 Cycloplegic Agents Manufacturer Market Share in 2021 3.5 Cycloplegic Agents Market: Overall Company Footprint Analysis 3.5.1 Cycloplegic Agents Market: Region Footprint 3.5.2 Cycloplegic Agents Market: Company Product Type Footprint 3.5.3 Cycloplegic Agents Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Cycloplegic Agents Market Size by Region 4.1.1 Global Cycloplegic Agents Sales Quantity by Region (2019-2030) 4.1.2 Global Cycloplegic Agents Consumption Value by Region (2019-2030) 4.1.3 Global Cycloplegic Agents Average Price by Region (2019-2030) 4.2 North America Cycloplegic Agents Consumption Value (2019-2030) 4.3 Europe Cycloplegic Agents Consumption Value (2019-2030) 4.4 Asia-Pacific Cycloplegic Agents Consumption Value (2019-2030) 4.5 South America Cycloplegic Agents Consumption Value (2019-2030) 4.6 Middle East and Africa Cycloplegic Agents Consumption Value (2019-2030) 5 Market Segment by Type 5.1 Global Cycloplegic Agents Sales Quantity by Type (2019-2030) 5.2 Global Cycloplegic Agents Consumption Value by Type (2019-2030) 5.3 Global Cycloplegic Agents Average Price by Type (2019-2030) 6 Market Segment by Application 6.1 Global Cycloplegic Agents Sales Quantity by Application (2019-2030) 6.2 Global Cycloplegic Agents Consumption Value by Application (2019-2030) 6.3 Global Cycloplegic Agents Average Price by Application (2019-2030) 7 North America 7.1 North America Cycloplegic Agents Sales Quantity by Type (2019-2030) 7.2 North America Cycloplegic Agents Sales Quantity by Application (2019-2030) 7.3 North America Cycloplegic Agents Market Size by Country 7.3.1 North America Cycloplegic Agents Sales Quantity by Country (2019-2030) 7.3.2 North America Cycloplegic Agents Consumption Value by Country (2019-2030) 7.3.3 United States Market Size and Forecast (2019-2030) 7.3.4 Canada Market Size and Forecast (2019-2030) 7.3.5 Mexico Market Size and Forecast (2019-2030) 8 Europe 8.1 Europe Cycloplegic Agents Sales Quantity by Type (2019-2030) 8.2 Europe Cycloplegic Agents Sales Quantity by Application (2019-2030) 8.3 Europe Cycloplegic Agents Market Size by Country 8.3.1 Europe Cycloplegic Agents Sales Quantity by Country (2019-2030) 8.3.2 Europe Cycloplegic Agents Consumption Value by Country (2019-2030) 8.3.3 Germany Market Size and Forecast (2019-2030) 8.3.4 France Market Size and Forecast (2019-2030) 8.3.5 United Kingdom Market Size and Forecast (2019-2030) 8.3.6 Russia Market Size and Forecast (2019-2030) 8.3.7 Italy Market Size and Forecast (2019-2030) 9 Asia-Pacific 9.1 Asia-Pacific Cycloplegic Agents Sales Quantity by Type (2019-2030) 9.2 Asia-Pacific Cycloplegic Agents Sales Quantity by Application (2019-2030) 9.3 Asia-Pacific Cycloplegic Agents Market Size by Region 9.3.1 Asia-Pacific Cycloplegic Agents Sales Quantity by Region (2019-2030) 9.3.2 Asia-Pacific Cycloplegic Agents Consumption Value by Region (2019-2030) 9.3.3 China Market Size and Forecast (2019-2030) 9.3.4 Japan Market Size and Forecast (2019-2030) 9.3.5 Korea Market Size and Forecast (2019-2030) 9.3.6 India Market Size and Forecast (2019-2030) 9.3.7 Southeast Asia Market Size and Forecast (2019-2030) 9.3.8 Australia Market Size and Forecast (2019-2030) 10 South America 10.1 South America Cycloplegic Agents Sales Quantity by Type (2019-2030) 10.2 South America Cycloplegic Agents Sales Quantity by Application (2019-2030) 10.3 South America Cycloplegic Agents Market Size by Country 10.3.1 South America Cycloplegic Agents Sales Quantity by Country (2019-2030) 10.3.2 South America Cycloplegic Agents Consumption Value by Country (2019-2030) 10.3.3 Brazil Market Size and Forecast (2019-2030) 10.3.4 Argentina Market Size and Forecast (2019-2030) 11 Middle East & Africa 11.1 Middle East & Africa Cycloplegic Agents Sales Quantity by Type (2019-2030) 11.2 Middle East & Africa Cycloplegic Agents Sales Quantity by Application (2019-2030) 11.3 Middle East & Africa Cycloplegic Agents Market Size by Country 11.3.1 Middle East & Africa Cycloplegic Agents Sales Quantity by Country (2019-2030) 11.3.2 Middle East & Africa Cycloplegic Agents Consumption Value by Country (2019-2030) 11.3.3 Turkey Market Size and Forecast (2019-2030) 11.3.4 Egypt Market Size and Forecast (2019-2030) 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030) 11.3.6 South Africa Market Size and Forecast (2019-2030) 12 Market Dynamics 12.1 Cycloplegic Agents Market Drivers 12.2 Cycloplegic Agents Market Restraints 12.3 Cycloplegic Agents Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Cycloplegic Agents and Key Manufacturers 13.2 Manufacturing Costs Percentage of Cycloplegic Agents 13.3 Cycloplegic Agents Production Process 13.4 Cycloplegic Agents Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Cycloplegic Agents Typical Distributors 14.3 Cycloplegic Agents Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer
It contains all the geographic trends, and market analysis for global market